Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Initial_Public_Offering
|
| gptkbp:date |
2018-07-18
|
| gptkbp:fundedBy |
$241 million
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:offeredBy |
$23 per share
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:RUBY
|
| gptkbp:subjectOf |
gptkb:Rubius_Therapeutics
|
| gptkbp:bfsParent |
gptkb:ARCH_Venture_Partners
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rubius Therapeutics IPO
|